- Home
- MAIA vs CLPR Comparison
MAIA vs CLPR Comparison
Compare MAIA & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAIA | CLPR |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.3M | 59.1M |
| IPO Year | 2022 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MAIA | CLPR |
|---|---|---|
| Price | $1.50 | $3.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 57.3K |
| Earning Date | 01-01-0001 | 06-05-2026 |
| Dividend Yield | N/A | ★ 12.18% |
| EPS Growth | ★ 29.53 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $109,997,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.82 |
| 52 Week Low | $0.87 | $3.04 |
| 52 Week High | $3.19 | $4.68 |
Technical Indicators
Market Signals| Indicator | MAIA | CLPR |
|---|---|---|
| Relative Strength Index (RSI) | 37.24 | 40.02 |
| Support Level | $1.20 | $3.04 |
| Resistance Level | $1.69 | $3.96 |
| Average True Range (ATR) | 0.18 | 0.13 |
| MACD | -0.08 | -0.01 |
| Stochastic Oscillator | 12.04 | 35.94 |
Price Performance
Historical ComparisonAbout MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.